IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?
in: Cytokine | Vol. 149 (2021), p. 155730
Re : Virus Load and Incidence of Olfactory, Gustatory, Respiratory, Gastrointestinal Disorders in COVID-19 Patients: A Retrospective Cohort Study
in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery | (12.11.2021)
Corticosteroid-related In-Hospital Hyperglycemia : Does It Negate Mortality Benefits in Coronavirus Disease 2019?
in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | Vol. 73, No. 9 (2021), p. e2848-e2849
The association between the use of ivermectin and mortality in patients with COVID-19 : a meta-analysis
in: Pharmacological reports : PR | Vol. 73, No. 5 (2021), p. 1473-1479